The investigators overall objective is to identify tumor-specific determinants that elicit MHC restricted CTL responses. To test this hypothesis he will follow two complementary approaches.
His specific aims are: 1) to clone and sequence the tumor- specific antigen(s) in ovarian carcinoma: (a) to construct on a cosmid vector a genomic DNA library from an appropriate ovarian carcinoma tumor cell clone expressing tumor-specific antigen(s); (b) to express the cosmid library into appropriate recipient cells; (c) to identify recipient cells expressing tumor- specific antigen(s) by their ability to stimulate autologous tumor specific TIL T cell clones to proliferate and/or produce cytokines and to confirm such expression using a cytotoxic assay; (d) to clone and sequence the tumor- specific antigen(s) from the recipient cells; (e) to employ a retroviral cDNA library approach, in the event that the cosmid library/transfection method does not allow for expression of tumor-specific antigen(s); and (f) to identify the peptides of the tumor- specific antigens recognized in association with MHC by autologous tumor- specific CTL. 2) To isolate and identify tumor- specific peptides from purified HLA class I from ovarian carcinoma tumor cell lines: (a) to isolate HLA-bound peptides from purified HLA class I from ovarian tumor cell lines, susceptible to lysis by MHC-restricted ovarian tumor-specific CTL lines/clones; (b) to determine the amino acid sequence of these peptides and whether they have been derived from known self proteins; (c) to determine if these peptides are tumor-specific by determining whether they render target cells, expressing the appropriate class I, susceptible to lysis by MHC-restricted ovarian tumor-specific CTL; and (d) in the event that the sequences of these tumor-specific peptides do not match to the tumor- specific antigen sequences obtained from the DNA cloning, to synthesize oligodeoxynucleotides corresponding to the sequence of the peptides and to clone the tumor-specific antigen(s) from an appropriate library.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA057884-03
Application #
2098617
Study Section
Experimental Immunology Study Section (EI)
Project Start
1992-09-30
Project End
1995-03-31
Budget Start
1993-09-30
Budget End
1995-03-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Temple University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Monos, Dimitri S; Pappas, John; Magira, Eleni E et al. (2005) Identification of HLA-DQalpha and -DRbeta residues associated with susceptibility and protection to epithelial ovarian cancer. Hum Immunol 66:554-62
Pappas, John; Jung, Weon-Ju; Barda, Angeliki K et al. (2005) Substantial proportions of identical beta-chain T-cell receptor transcripts are present in epithelial ovarian carcinoma tumors. Cell Immunol 234:81-101
Platsoucas, Chris D; Fincke, John E; Pappas, John et al. (2003) Immune responses to human tumors: development of tumor vaccines. Anticancer Res 23:1969-96
Kooi, S; Zhang, H Z; Patenia, R et al. (1996) HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2. Cell Immunol 174:116-28
Freedman, R S; Platsoucas, C D (1996) Immunotherapy for peritoneal ovarian carcinoma metastasis using ex vivo expanded tumor infiltrating lymphocytes. Cancer Treat Res 82:115-46
Nash, M A; Platsoucas, C D; Wong, B Y et al. (1995) Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vector. Hum Gene Ther 6:1379-89
Mitropoulos, D; Kooi, S; Rodriguez-Villanueva, J et al. (1994) Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma. Clin Exp Immunol 97:321-7
Freedman, R S; Tomasovic, B; Templin, S et al. (1994) Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy. J Immunol Methods 167:145-60
Lee, J E; Reveille, J D; Ross, M I et al. (1994) HLA-DQB1*0301 association with increased cutaneous melanoma risk. Int J Cancer 59:510-3
Chen, P F; Freedman, R S; Chernajovsky, Y et al. (1994) Amplification of immunoglobulin transcripts by the non-palindromic adaptor polymerase chain reaction (NPA-PCR). Nucleotide sequence analysis of two human monoclonal antibodies recognizing two cell surface antigens expressed in ovarian, cervix, breast, col Hum Antibodies Hybridomas 5:131-42

Showing the most recent 10 out of 13 publications